HSP Related Downgrades

May 2, 2013 08:22 AM Raymond James Downgrades Hospira (HSP) to Underperform

Feb 26, 2013 09:37 AM Gabelli Downgrades Hospira (HSP) to Hold

Feb 13, 2013 12:33 PM BofA/Merrill Lynch Downgrades Hospira (HSP) to Neutral

Aug 9, 2012 06:53 AM JPMorgan Downgrades Hospira (HSP) to Neutral

Feb 17, 2012 07:30 AM Citi Downgrades Hospira (HSP) to Sell, Lifts Price Target to $33

Jan 10, 2012 03:33 PM Raymond James Downgraded Four Medical Instruments & Supplies Stocks

Jan 10, 2012 11:23 AM Raymond James Downgrades Hospira (HSP) to Market Perform

Dec 19, 2011 12:30 PM Bernstein Cuts Hospira (HSP) to Market Perform

Oct 19, 2011 07:38 AM Capstone Investments Downgrades Hospira (HSP) to Hold

Oct 18, 2011 01:29 PM Hospira (HSP) Shares Downgraded at Ticonderoga Following Concerning Guidance

Oct 18, 2011 01:27 PM Buckingham Cuts Hospira (HSP) to Neutral

Oct 18, 2011 01:06 PM Leerink Swann Downgrades Hospira (HSP) to Market Perform, Cuts Price Target by 40%

Sep 13, 2011 11:59 AM UPDATE - Barclays Downgraded Hospira (HSP) to Equalweight; Expecting a Challenging 2012

Sep 13, 2011 07:51 AM Barclays Downgrades Hospira (HSP) to Equalweight

Sep 8, 2011 08:13 AM Raymond James Downgrades Hospira (HSP) to Outperform

May 11, 2011 07:08 AM Goldman Sachs Downgrades Hospira (HSP) to Neutral

Apr 27, 2011 07:58 AM Citi Downgrades Hospira (HSP) to Sell

Sep 28, 2010 08:15 AM Citi Cuts Hospira (HSP) to Sell, Price Target Moved from $58 to $52

Jul 15, 2010 07:56 AM Bernstein Downgrades Hospira (HSP) to Market Perform

Jan 20, 2009 09:12 AM Soleil Securities Downgrades Hospira (HSP) to Hold

Apr 16, 2008 11:31 AM Matrix USA Rating Changes 4/16

Apr 10, 2008 08:21 AM Morgan Stanley downgrades Hospira (HSP) to Equal Weight

Mar 24, 2006 08:43 AM Matrix downgrades Hospira (HSP) to Sell

Aug 11, 2005 07:51 AM HSP Tops Q2 Views; Guides Above

Jun 8, 2005 08:37 AM KeyBanc Downgraded HSP